Nova Leap Health Dividend

Dividend criteriumcontroles 0/6

Nova Leap Health does not have a record of paying a dividend.

Belangrijke informatie

n/a

Dividendrendement

-0.2%

Terugkoop Rendement

Totaal aandeelhoudersrendement	-0.2%
Toekomstig dividendrendement	n/a
Dividendgroei	n/a
Volgende betaaldatum dividend	n/a
Ex-dividenddatum	n/a
Dividend per aandeel	n/a
Uitbetalingsratio	n/a

Recente dividendupdates

Geen updates

Recent updates

Nova Leap Health Corp.'s (CVE:NLH) 35% Share Price Surge Not Quite Adding Up

Oct 31

Risks Still Elevated At These Prices As Nova Leap Health Corp. (CVE:NLH) Shares Dive 27%

Sep 12

Nova Leap Health Corp.'s (CVE:NLH) 33% Price Boost Is Out Of Tune With Revenues

Jun 08

Should Shareholders Reconsider Nova Leap Health Corp.'s (CVE:NLH) CEO Compensation Package?

May 31

Stabiliteit en groei van betalingen

Dividenden ophalen

Stabiel dividend: Insufficient data to determine if NLH's dividends per share have been stable in the past.

Groeiend dividend: Insufficient data to determine if NLH's dividend payments have been increasing.

Dividendrendement versus markt

Nova Leap Health Dividendrendement versus markt

Hoe verhoudt NLH dividendrendement zich tot de markt?
Segment	Dividendrendement
Bedrijf (NLH)	n/a
Markt onderkant 25% (CA)	1.8%
Markt Top 25% (CA)	6.1%
Gemiddelde industrie (Healthcare)	3.7%
Analist prognose (NLH) (tot 3 jaar)	n/a

Opmerkelijk dividend: Unable to evaluate NLH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Hoog dividend: Unable to evaluate NLH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Winstuitkering aan aandeelhouders

Verdiendekking: Insufficient data to calculate NLH's payout ratio to determine if its dividend payments are covered by earnings.

Contante uitbetaling aan aandeelhouders

Kasstroomdekking: Unable to calculate sustainability of dividends as NLH has not reported any payouts.

Nova Leap Health Dividend

Dividend criteriumcontroles 0/6

Belangrijke informatie

Recente dividendupdates

Recent updates

Nova Leap Health Corp.'s (CVE:NLH) 35% Share Price Surge Not Quite Adding Up

Risks Still Elevated At These Prices As Nova Leap Health Corp. (CVE:NLH) Shares Dive 27%

New minor risk - Share price stability

Second quarter 2024 earnings released: EPS: US$0.003 (vs US$0.002 loss in 2Q 2023)

Nova Leap Health Corp.'s (CVE:NLH) 33% Price Boost Is Out Of Tune With Revenues

Should Shareholders Reconsider Nova Leap Health Corp.'s (CVE:NLH) CEO Compensation Package?

First quarter 2024 earnings released: EPS: US$0.005 (vs US$0.003 loss in 1Q 2023)

Insufficient new directors

Nova Leap Health Corp., Annual General Meeting, Jun 07, 2024

Nova Leap Health Corp. (CVE:NLH) Looks Just Right With A 28% Price Jump

Full year 2023 earnings released

Market Participants Recognise Nova Leap Health Corp.'s (CVE:NLH) Revenues

Second quarter 2023 earnings released: US$0.002 loss per share (vs US$0 in 2Q 2022)

Nova Leap Health Corp. Announces Impairment for the Second Quarter Ended June 30, 2023

Nova Leap Health Corp. to Report Q2, 2023 Results on Aug 10, 2023

Nova Leap Health Corp. Announces Change of Corporate Secretary

Nova Leap Health Corp. (CVE:NLH) Investors Are Less Pessimistic Than Expected

New minor risk - Share price stability

Independent Director recently bought CA$99k worth of stock

First quarter 2023 earnings released: US$0.003 loss per share (vs US$0.005 loss in 1Q 2022)

Full year 2022 earnings released: US$0.01 loss per share (vs US$0.024 profit in FY 2021)

Does Nova Leap Health (CVE:NLH) Have A Healthy Balance Sheet?

Third quarter 2022 earnings released: EPS: US$0.007 (vs US$0.016 in 3Q 2021)

Third quarter 2022 earnings released: EPS: US$0.007 (vs US$0.016 in 3Q 2021)

Now 22% undervalued after recent price drop

Now 27% undervalued after recent price drop

Nova Leap Health Corp. announced that it has received CAD 2.385056 million in funding

Nova Leap Health Corp. announced that it expects to receive CAD 2.5 million in funding

Independent Director recently bought CA$94k worth of stock

Now 23% undervalued after recent price drop

Calculating The Intrinsic Value Of Nova Leap Health Corp. (CVE:NLH)

Second quarter 2022 earnings released: EPS: US$0 (vs US$0.005 in 2Q 2021)

Nova Leap Health (CVE:NLH) Is Carrying A Fair Bit Of Debt

First quarter 2022 earnings released: US$0.005 loss per share (vs US$0.013 profit in 1Q 2021)

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Nova Leap Health Corp., Annual General Meeting, Apr 21, 2022

Independent Director recently bought CA$99k worth of stock

Nova Leap Health Corp. (TSXV:NLH) completed the acquisition of Home Care Business With Operations Located in Kentucky and Indiana.

Independent Chairman of the Board recently bought CA$53k worth of stock

Third quarter 2021 earnings released: EPS US$0.02 (vs US$0.007 in 3Q 2020)

Estimating The Intrinsic Value Of Nova Leap Health Corp. (CVE:NLH)

Nova Leap Health Corp. (TSXV:NLH) acquired Business assets of a home care services company located in Oklahoma.

Second quarter 2021 earnings released: EPS US$0.01 (vs US$0.012 loss in 2Q 2020)

Independent Director exercised options to buy CA$228k worth of stock.

Nova Leap Health Corp entered into an agreement to acquire Home care services company.

Nova Leap Health Corp. announced that it has received CAD 5.499999 million in funding

Nova Leap Health Corp. announced that it expects to receive CAD 1.999999 million in funding

First quarter 2021 earnings released: EPS US$0.01 (vs US$0.005 in 1Q 2020)

Nova Leap Health Corp. Appoints Marie Mullally to Board of Directors

Nova Leap Health (CVE:NLH) Strong Profits May Be Masking Some Underlying Issues

Full year 2020 earnings released: EPS US$0.02 (vs US$0.017 loss in FY 2019)

Revenue misses expectations

Nova Leap Health Corp., Annual General Meeting, Apr 29, 2021

New 90-day high: CA$0.87

New 90-day high: CA$0.58

Third quarter 2020 earnings released: EPS US$0.01

New 90-day high: CA$0.48

New 90-day high: CA$0.40

New 90-day high - CA$0.38

Earnings released

New 90-day low - CA$0.30

Stabiliteit en groei van betalingen

Dividendrendement versus markt

Winstuitkering aan aandeelhouders

Contante uitbetaling aan aandeelhouders

Ontdek bedrijven met een sterk dividend